Grenader A C, O'Rourke D A, Healy D P
Department of Pharmacology, Mount Sinai School of Medicine, City University of New York, New York 10029.
Am J Physiol. 1995 Mar;268(3 Pt 2):F423-34. doi: 10.1152/ajprenal.1995.268.3.F423.
The porcine renal epithelial cell line LLC-PK1 expresses a D1 dopamine receptor coupled to stimulation of adenylyl cyclase. The molecular identity of this receptor is unknown. We isolated a partial cDNA from LLC-PK1 poly(A)+ RNA by the reverse transcription-polymerase chain reaction procedure with degenerate D1 receptor oligonucleotide primers and used the partial cDNA to screen a porcine genomic library. One such genomic clone (lambda PGD1A.1) contained an open-reading frame that encoded a 446-amino-acid protein that is 95% identical to the human D1A receptor. The functional properties of the genomic clone transiently transfected into COS-7 cells were consistent with expression of a D1 receptor. RNA hybridization analyses with LLC-PK1 poly(A)+ RNA were positive. Primer extension analysis indicated that the primary transcription initiation site of the porcine D1A gene expressed in LLC-PK1 cells is 1,033 nucleotides upstream from the translation start site. The 5'-flanking region of the gene lacks a TATA and CAAT box but is high in GC content (68%) and contains multiple Sp1 binding sites. There is a 97-bp intron within the 5'-noncoding region, separating exons 1 and 2. These results add support to the view that the D1A receptor is the major D1 receptor expressed in kidney and further suggest that LLC-PK1 cells may be a useful model for study of the regulation of the renal D1A receptor gene.
猪肾上皮细胞系LLC-PK1表达一种与腺苷酸环化酶刺激偶联的D1多巴胺受体。该受体的分子特性尚不清楚。我们通过使用简并D1受体寡核苷酸引物的逆转录-聚合酶链反应程序,从LLC-PK1聚腺苷酸加尾RNA中分离出一个部分cDNA,并使用该部分cDNA筛选猪基因组文库。一个这样的基因组克隆(λPGD1A.1)包含一个开放阅读框,其编码一个446个氨基酸的蛋白质,该蛋白质与人D1A受体有95%的同一性。瞬时转染到COS-7细胞中的基因组克隆的功能特性与D1受体的表达一致。用LLC-PK1聚腺苷酸加尾RNA进行的RNA杂交分析呈阳性。引物延伸分析表明,在LLC-PK1细胞中表达的猪D1A基因的初级转录起始位点在翻译起始位点上游1033个核苷酸处。该基因的5'侧翼区缺乏TATA盒和CAAT盒,但GC含量高(68%),并含有多个Sp1结合位点。在5'非编码区内有一个97bp的内含子,将外显子1和外显子2分开。这些结果进一步支持了D1A受体是在肾脏中表达的主要D1受体这一观点,并进一步表明LLC-PK1细胞可能是研究肾D1A受体基因调控的有用模型。